Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nabriva (NBRV – Research Report) and Venus Concept (VERO – Research Report).
Nabriva (NBRV)
H.C. Wainwright analyst Ed Arce maintained a Hold rating on Nabriva today. The company’s shares closed last Thursday at $2.18, close to its 52-week low of $2.04.
According to TipRanks.com, Arce is a 3-star analyst with an average return of
The the analyst consensus on Nabriva is currently a Hold rating.
See the top stocks recommended by analysts >>
Venus Concept (VERO)
BTIG analyst Marie Thibault maintained a Buy rating on Venus Concept today and set a price target of $1.00. The company’s shares closed last Thursday at $0.21, close to its 52-week low of $0.20.
According to TipRanks.com, Thibault is a 4-star analyst with an average return of
Currently, the analyst consensus on Venus Concept is a Moderate Buy with an average price target of $1.38.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on NBRV:
- Inflation at 7.7%: 2 ‘Strong Buy’ Dividend Stocks That Beat This Rate
- TaskUs to Participate at November 2022 Investor Conferences
- Barrington Remains a Buy on Nexstar Media Group (NXST)
- Intermex Reports Enhancements to Its Credit Agreement
- Pet Valu Holdings Ltd. Announces Increase of Previously Announced Secondary Bought Deal Offering to C$168 Million
